机构:[1]Department of Hepatobiliary Surgery, Academician (Expert) Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong 637600, China.[2]State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.[3]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, China.[4]Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Major State Basic Research
Development Program of China (2017YFA0205201), the
National Natural Science Foundation of China (81925019,
81422023, 81603015, 81871404, 82003147, U22A20333 and
U1705281), the Nuclear Medicine and Molecular Imaging Key
Laboratory of Sichuan Province Open Project (HYX20003), the
Chengdu Gaoxin Medical Association 2020 Annual Cancer
Intervention Special Research Fund (2020S02) and the
Popularization and Application Project of Sichuan Health
Commission (20PJ149).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区医学
小类|2 区材料科学:生物材料
最新[2023]版:
大类|1 区医学
小类|2 区材料科学:生物材料
第一作者:
第一作者机构:[1]Department of Hepatobiliary Surgery, Academician (Expert) Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong 637600, China.[2]State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xiong Yongfu,He Pan,Zhang Yang,et al.Superstable homogeneous lipiodol-ICG formulation: initial feasibility and first-in-human clinical application for ruptured hepatocellular carcinoma[J].Regenerative biomaterials.2023,10:rbac106.doi:10.1093/rb/rbac106.